Literature DB >> 24800119

Neurotoxicity with combined use of lithium and haloperidol decanoate.

Michelle D Colvard1, John D Gentry1, Diana M Mullis1.   

Abstract

Entities:  

Year:  2013        PMID: 24800119      PMCID: PMC3977768          DOI: 10.4088/PCC.13l01563

Source DB:  PubMed          Journal:  Prim Care Companion CNS Disord        ISSN: 2155-7780


× No keyword cloud information.
  8 in total

1.  Adverse reactions in treatment with lithium carbonate and haloperidol.

Authors:  P C Baastrup; P Hollnagel; R Sorensen; M Schou
Journal:  JAMA       Date:  1976-12-06       Impact factor: 56.272

2.  Lithium carbonate, haloperidol, and irreversible brain damage.

Authors:  W J Cohen; N H Cohen
Journal:  JAMA       Date:  1974-12-02       Impact factor: 56.272

3.  Effect of lithium on brain dopamine.

Authors:  E Friedman; S Gershon
Journal:  Nature       Date:  1973-06-29       Impact factor: 49.962

4.  Correlation of neuroleptic dose and neurotoxicity in patients given lithium and a neuroleptic.

Authors:  F Miller; J Menninger
Journal:  Hosp Community Psychiatry       Date:  1987-11

5.  Toxic reactions to lithium and haloperidol.

Authors:  J B Loudon; H Waring
Journal:  Lancet       Date:  1976-11-13       Impact factor: 79.321

6.  Effect of neuroleptic drugs on lithium uptake by the human erythrocyte.

Authors:  G N Pandey; I Goel; J M Davis
Journal:  Clin Pharmacol Ther       Date:  1979-07       Impact factor: 6.875

7.  Neurotoxicity with combined use of lithium and thioridazine.

Authors:  G K Spring
Journal:  J Clin Psychiatry       Date:  1979-03       Impact factor: 4.384

8.  New data on lithium and haloperidol incompatibility.

Authors:  G Spring; M Frankel
Journal:  Am J Psychiatry       Date:  1981-06       Impact factor: 18.112

  8 in total
  1 in total

1.  Impact of lithium alone or in combination with haloperidol on selected oxidative stress parameters in human plasma in vitro.

Authors:  Oliwia Gawlik-Kotelnicka; Wojciech Mielicki; Jolanta Rabe-Jabłońska; Dominik Strzelecki
Journal:  Redox Rep       Date:  2016-03-08       Impact factor: 4.412

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.